Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.
Jie GL, Peng LX, Zheng MM, Sun H, Wang SR, Liu SM, Yin K, Chen ZH, Tian HX, Yang JJ, Zhang XC, Tu HY, Zhou Q, Wong CCL, Wu YL.
Jie GL, et al. Among authors: tian hx.
Cancers (Basel). 2023 Jan 1;15(1):302. doi: 10.3390/cancers15010302.
Cancers (Basel). 2023.
PMID: 36612298
Free PMC article.